[1]
G. G. ASANOME, G. C. HALILA, e J. B. DAHER, “INFLUENCE OF INDIVIDUALIZED PHARMACOTHERAPEUTIC MONITORING IN ADOLESCENT PACIENT WITH TYPE 1 DIABETES MELLITUS”, VA, vol. 13, nº 4, dez. 2012.